214 related articles for article (PubMed ID: 3245731)
21. Cardiac and coronary vasodilator profile of pimobendan, a new cardiotonic drug, revealed by use of isolated, blood-perfused dog heart preparations.
Imagawa J; Satoh K; Taira N
Heart Vessels; 1987; 3(4):182-9. PubMed ID: 3453824
[TBL] [Abstract][Full Text] [Related]
22. Profile of cardiac and coronary vasodilator effects of MS-857, a novel cardiotonic agent, assessed in isolated, blood-perfused heart preparations of the dog.
Maruyama M; Kamiya J; Kobari T
J Cardiovasc Pharmacol; 1989 Nov; 14(5):777-82. PubMed ID: 2481193
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms underlying the cardiovascular action of a new dihydropyridine vasodilator YC-93.
Satoh K; Yanagisawa T; Taira N
Clin Exp Pharmacol Physiol; 1980; 7(3):249-62. PubMed ID: 7406961
[TBL] [Abstract][Full Text] [Related]
24. Is the cardiovascular profile of BRL 34915 characteristic of potassium channel activators?
Gotanda K; Satoh K; Taira N
J Cardiovasc Pharmacol; 1988 Aug; 12(2):239-46. PubMed ID: 2459556
[TBL] [Abstract][Full Text] [Related]
25. Cardiovascular profile of Bay K 8644, a presumed calcium channel activator, in the dog.
Wada Y; Satoh K; Taira N
Naunyn Schmiedebergs Arch Pharmacol; 1985 Feb; 328(4):382-7. PubMed ID: 2581147
[TBL] [Abstract][Full Text] [Related]
26. Mode and mechanism of action of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212), a novel positive inotropic drug, on the dog heart.
Taira N; Endoh M; Iijima T; Satoh K; Yanagisawa T; Yamashita S; Maruyama M; Kawada M; Morita T; Wada Y
Arzneimittelforschung; 1984; 34(3A):347-55. PubMed ID: 6331465
[TBL] [Abstract][Full Text] [Related]
27. Comparative effects of gallopamil and verapamil on the mechanical and electrophysiological parameters of isolated guinea-pig myocardium.
Noguchi K; Masumiya H; Takahashi K; Kaneko K; Higuchi S; Tanaka H; Shigenobu K
Can J Physiol Pharmacol; 1997 Dec; 75(12):1316-21. PubMed ID: 9534940
[TBL] [Abstract][Full Text] [Related]
28. Similarity and dissimilarity in mode and mechanism of action between YT-146, a selective adenosine receptor A2 agonist, and adenosine in isolated canine hearts.
Yoneyama F; Aihara K; Kogi K; Satoh K; Taira N
Tohoku J Exp Med; 1999 May; 188(1):31-45. PubMed ID: 10494898
[TBL] [Abstract][Full Text] [Related]
29. Comparative study of cardiovascular profiles of milrinone and amrinone by use of isolated, blood-perfused dog heart preparations.
Sato Y; Wada Y; Taira N
Heart Vessels; 1986; 2(4):213-20. PubMed ID: 3571104
[TBL] [Abstract][Full Text] [Related]
30. Effects of verapamil on automaticity and conduction with particular reference to tachyphylaxis.
Lupi GA; Urthaler F; James TN
Eur J Cardiol; 1979 May; 9(5):345-68. PubMed ID: 456394
[TBL] [Abstract][Full Text] [Related]
31. Calcium-antagonist effects of norbormide on isolated perfused heart and cardiac myocytes of guinea-pig: a comparison with verapamil.
Bova S; Cargnelli G; D'Amato E; Forti S; Yang Q; Trevisi L; Debetto P; Cima L; Luciani S; Padrini R
Br J Pharmacol; 1997 Jan; 120(1):19-24. PubMed ID: 9117093
[TBL] [Abstract][Full Text] [Related]
32. [Action of the calciumantagonistic compound gallopamile on sinus node, atrioventricular and intraventricular conduction (author's transl)].
Beck OA; Witt E; Lehmann HU; Hochrein H
Z Kardiol; 1978 Aug; 67(8):522-6. PubMed ID: 695803
[TBL] [Abstract][Full Text] [Related]
33. Cardiac versus coronary vasodilator actions of isobutylmethylxanthine in dogs: comparison with theophylline.
Takahashi K; Wada Y; Taira N
Jpn J Pharmacol; 1986 May; 41(1):23-32. PubMed ID: 2426501
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological profile of a new coronary vasodilator drug, 2-nicotinamidoethyl nitrate (SG-75).
Taira N; Satoh K; Yanagisawa T; Imai Y; Hiwatari M
Clin Exp Pharmacol Physiol; 1979; 6(3):301-16. PubMed ID: 157241
[TBL] [Abstract][Full Text] [Related]
35. Characterization of cardiovascular actions of CS-611, a new coronary dilator, in the dog.
Motomura S; Satoh K; Yamashita S; Taira N
Arzneimittelforschung; 1981; 31(8):1238-44. PubMed ID: 7197528
[TBL] [Abstract][Full Text] [Related]
36. [Treatment of heart arrhythmias with calcium antagonists].
Bender F
Z Kardiol; 1984; 73 Suppl 2():101-5. PubMed ID: 6084911
[TBL] [Abstract][Full Text] [Related]
37. Cardiovascular effects of (2RS,3SR)- 2-aminomethyl-2,3,7,8-tetrahydro-2,3,5,8,8-pentamethyl-6H-furo- [2,3-e]indol-7-one hydrochloride (UK-1745), a novel cardiotonic agent with vasodilatory and antiarrhythmic properties.
Uchida Y; Kawada M; Sawanobori K; Sonoki H; Inoue K; Mizuno K; Itou T; Tabunoki Y; Tsukamoto M; Ohashi Y; Kyotani Y; Shimizu N; Fujii M; Nakamura M
Arzneimittelforschung; 1998 Mar; 48(3):219-31. PubMed ID: 9553677
[TBL] [Abstract][Full Text] [Related]
38. Comparison of cardiovascular effects of a new calcium channel blocker AH-1058 with those of verapamil assessed in blood-perfused canine heart preparations.
Takahara A; Sugiyama A; Dohmoto H; Yoshimoto R; Hashimoto K
J Cardiovasc Pharmacol; 2000 May; 35(5):741-8. PubMed ID: 10813376
[TBL] [Abstract][Full Text] [Related]
39. Cardiac effects of amiloride in the dog.
Yamashita S; Motomura S; Taira N
J Cardiovasc Pharmacol; 1981; 3(4):704-15. PubMed ID: 6167801
[TBL] [Abstract][Full Text] [Related]
40. Is antagonism by Bay k 8644 of the negative dromotropic effect of nifedipine pharmacological?
Taira N; Wada Y; Satoh K
J Pharmacol Exp Ther; 1985 Jan; 232(1):244-50. PubMed ID: 2578189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
